Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after ...

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in ...

A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending ...

Researchers at the Case Western Reserve School of Medicine have found that when compared to seven other anti-diabetic drugs, ...

A couple from Hull have called on the government to fund new Alzheimer's drugs, even though they say it will come "too late" ...

Alzheimer’s Research UK called the decision "disappointing" and added: “While these drugs are not cures and come with risk of side-effects, trials show they are the first treatments to slow the ...

Even if these drugs are ultimately proved to be ineffective for memory loss, she says they are already known to reduce the ...

New Alzheimer’s drug rejected for NHS use – because it’s not worth the money - Alzheimer’ patients in UK left behind over ...

The headline-making drug has been linked to the death of Liam Payne and named in a civil lawsuit against Sean “Diddy” Combs.

A wife whose husband will not be eligible for new Alzheimer’s drugs has implored health leaders to ensure that others like ...

A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making ...

A close friend of Liam Payne has claimed that the singer was “preyed” on by drug dealers during his ill-fated trip to ...